Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation TCT 2021

Leading with Evidence: Latest Data on Renal Denervation

Presenter: NULL

November 06, 2021

Presentation TCT 2021

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Presenter: David E. Kandzari

November 04, 2021

News Conference News TCT 2021

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Todd Neale

November 04, 2021

Presentation TCT 2021

RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration

Presenter: Ajay Kirtane

November 04, 2021

Presentation TCT 2021

TCT 677: Renal denervation in a young patient with malignant hypertension

Presenter: Maria Antonieta Lopes

November 04, 2021

Presentation TCT 2021

TCT 633: A Clinical Case of Performing Optical CoherenceTomography of the Renal Arteries During Carboxyangiography to Assess the Safety of the Renal Denervation Procedure in a Patient With Uncontrolled Hypertension and Iodine-Containing Contrast Allergy.

Presenter: Mikhail Tarasov

November 04, 2021

News Opinion Editor's Corner TCT 2021

In-Person and Online: TCT to Showcase Imaging, Valves, DCBs, and More

Shelley Wood

November 01, 2021

News Daily News

Renal Denervation a Third Option for Hypertension, European Experts Say

Todd Neale

September 17, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2021

Shelley Wood

May 31, 2021

News Conference News ACC 2021

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Michael O'Riordan

May 16, 2021

Presentation ACC 2021

Ultrasound Renal Denervation for Hypertension Resistant to a Triple Medication Pill: The Randomized Sham Controlled RADIANCE-HTN TRIO Trial

Presenter: Ajay J. Kirtane

May 16, 2021

Video

» Interview

RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration

November 7, 2021

Advertisement

Leading with Evidence: Latest Data on Renal Denervation

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration

TCT 677: Renal denervation in a young patient with malignant hypertension

TCT 633: A Clinical Case of Performing Optical CoherenceTomography of the Renal Arteries During Carboxyangiography to Assess the Safety of the Renal Denervation Procedure in a Patient With Uncontrolled Hypertension and Iodine-Containing Contrast Allergy.

In-Person and Online: TCT to Showcase Imaging, Valves, DCBs, and More

Renal Denervation a Third Option for Hypertension, European Experts Say

TCTMD’s Top 10 Most Popular Stories for May 2021

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Ultrasound Renal Denervation for Hypertension Resistant to a Triple Medication Pill: The Randomized Sham Controlled RADIANCE-HTN TRIO Trial

RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content